Bach Option’s CME Group CME Stock Holding History

Bach Option’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,441	Closed	-$237K	–	88
2019 Q1	$237K	Buy	+1,441	New	+$255K	0.1%	83

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bach Option's CME Position: Q2 2019 in Review

Bach Option sold out of CME Group (CME) in Q2 2019, closing a stake of 1,441 shares — an estimated $237K sold.

Bach Option first reported a position in CME in Q1 2019 and held it in 1 quarter. The position peaked at $237K in Q1 2019. 978 funds tracked by Wall St. Rank hold CME as of Q2 2019.

Bach Option reported no remaining CME Group position as of Q2 2019 after selling out during the quarter.
Bach Option sold 1,441 CME Group shares in Q2 2019, an estimated $237K.
Bach Option first reported a position in CME Group in Q1 2019 and held it in 1 quarter.
Bach Option's CME Group position peaked at $237K in Q1 2019.
978 funds tracked by Wall St. Rank held CME Group as of Q2 2019.

Based on Bach Option's 13F filing for Q2 2019, filed 25 Jul 2019.